-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Lexaria Bioscience Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2016 to Q3 2024.
- Lexaria Bioscience Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending August 31, 2024 was $10.7M, a 12% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)